1211758-64-3

Upstream product

• 134419-59-3 4-oxanyl methanesulfonate 
• 446-36-6 5-fluoro-2-nitrophenol 
• 2081-44-9 Tetrahydro-pyran-4-ol 

Downstream Products

• 1211758-65-4 4-fluoro-2-(tetrahydro-2H-pyran-4-yloxy)aniline 
• 1211757-61-7 4-[4-Fluoro-2-(tetrahydro-pyran-4-yloxy)-phenylamino]-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylic acid methyl ester 
• 1211757-62-8 4-(4-fluoro-2-(tetrahydro-2H-pyran-4-yloxy)phenylamino)-5-methylthieno[2,3-d]pyrimidine-6-carboxylic acid 
• 1332710-62-9 4-[4-Fluoro-2-(tetrahydro-pyran-4-yloxy)-phenylamino]-5-methyl-thieno[2,3-d]pyrimidine-6-carboxylic acid (4-methyl-morpholin-2-ylmethyl)-amide trifluoracetate 
• 1233540-99-2 2-(methylsulfonyl)-5-[4-nitro-3-(tetrahydro-2H-pyran-4-yloxy)phenoxy]pyridine 
• 1233540-71-0 4-{[6-(Methoxymethyl)pyridin-3-yl]oxy}-2-(tetrahydro-2H-pyran-4-yloxy)aniline 
• 1233540-72-1 ethyl (2E)-2-{[4-{[6-(methoxymethyl)pyridin-3-yl]oxy}-2-(tetrahydro-2H-pyran-4-yloxy)phenyl]hydrazono}propanoate 
• 1233541-00-8 4-{[6-(Methylsulfonyl)pyridin-3-yl]oxy}-2-(tetrahydro-2H-pyran-4-yloxy)aniline 
• 1233541-01-9 ethyl 2-{[4-{[6-(methylsulfonyl)pyridin-3-yl]oxy}-2-(tetrahydro-2H-pyran-4-yloxy)phenyl]hydrazono}propanoate 
• 1233540-86-7 ethyl (2E)-2-{[4-({6-[(2-methoxyethoxy)methyl]pyridin-3-yl}oxy)-2-(tetrahydro-2H-pyran-4-yloxy)phenyl]hydrazono}propanoate 
• 1233540-85-6 4-({6-[(2-Methoxyethoxy)methyl]pyridin-3-yl}oxy)-2-(tetrahydro-2H-pyran-4-yloxy)aniline 
• 1233540-75-4 5-{[6-(methoxymethyl)pyridin-3-yl]oxy}-7-(tetrahydro-2H-pyran-4-yloxy)-1H-indole-2-carboxamide 
• 1233540-74-3 5-{[6-(methoxymethyl)pyridin-3-yl]oxy}-7-(tetrahydro-2H-pyran-4-yloxy)-1H-indole-2-carboxylic acid 
• 1233540-73-2 ethyl 5-{[6-(methoxymethyl)pyridin-3-yl]oxy}-7-(tetrahydro-2H-pyran-4-yloxy)-1H-indole-2-carboxylate 

Relevant academic research and scientific papers

HETEROCYCLOALKYL-CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositio

HETEROCYCLOALKYL-CONTAINING THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositio

NOVEL FUSED RING COMPOUND AND USE THEREOF

The present invention provides an agent for the prophylaxis or treatment of diabetes, obesity and the like, a glucokinase activator, containing a compound represented by the formula (I): wherein each symbol is as defined in the description, or a salt ther

THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS

The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds according to formula (I). Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of